Skip to main content

Table 2 Clinicoparhological characteristics of patients with early-stage ovarian cancer

From: Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

Factor

n

%

Age

  

<50

24

51.1

> = 50

23

48.9

Histology

  

Serous/endometrioid

14

29.8

Mucinous/clear cell

33

70.2

Stage

  

Ia/b

15

31.9

Ic/II

32

68.1